There have been 50 recent insider transactions recorded for LadRx Corporation (CYTR), including 36 buys and 7 sells. Total insider buying was valued at $12.49M and total insider selling at $1.18M.
Notable insiders with recent activity include Claiborne Cary J, Snowdy Stephen, Simpson Jennifer K.. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — CYTR
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2022-07-27 |
Claiborne Cary J |
Director |
Unknown |
- |
- |
- |
- |
| 2022-01-10 |
Snowdy Stephen |
Officer |
Unknown |
- |
- |
- |
- |
| 2022-01-10 |
Snowdy Stephen |
Chief Executive Officer |
RSU Award |
300,000 |
$0.64 |
$192.3K |
300,000 |
| 2021-12-15 |
Simpson Jennifer K. |
Director |
RSU Award |
50,000 |
$0.45 |
$22.5K |
50,000 |
| 2021-12-15 |
Simpson Jennifer K. |
Director |
RSU Award |
25,000 |
- |
- |
25,000 |
| 2021-07-29 |
Simpson Jennifer K. |
Director |
Unknown |
- |
- |
- |
- |
| 2020-08-14 |
Brien Earl W |
Director |
Option Exercise (Sell) |
150,000 |
$0.26 |
$39K |
300,000 |
| 2020-08-07 |
Kriegsman Steven A |
Chief Executive Officer |
Option Exercise (Sell) |
3,000,000 |
$0.26 |
$780K |
- |
| 2020-08-07 |
Ignarro Louis |
Director |
Option Exercise (Sell) |
700,000 |
$0.26 |
$182K |
- |
| 2020-08-07 |
Caldwell Joel K |
Director |
Option Exercise (Sell) |
450,000 |
$0.26 |
$117K |
- |
| 2019-12-13 |
Kriegsman Steven A |
CEO |
RSU Award |
3,000,000 |
$0.26 |
$780K |
3,000,000 |
| 2019-12-13 |
Caloz John Y |
Chief Financial Officer |
RSU Award |
350,000 |
$0.26 |
$91K |
350,000 |
| 2019-12-13 |
Ignarro Louis |
Director |
RSU Award |
700,000 |
$0.26 |
$182K |
700,000 |
| 2019-12-13 |
Brien Earl W |
Director |
RSU Award |
450,000 |
$0.26 |
$117K |
450,000 |
| 2019-12-13 |
Caldwell Joel K |
Director |
RSU Award |
450,000 |
$0.26 |
$117K |
450,000 |
| 2018-05-03 |
Curtis Eric |
Officer |
Unknown |
- |
- |
- |
- |
| 2017-12-15 |
Kratz Felix |
Officer |
Unknown |
- |
- |
- |
- |
| 2017-12-15 |
Kratz Felix |
Vice President Drug Discovery |
RSU Award |
25,000 |
$1.75 |
$43.75K |
25,000 |
| 2017-12-15 |
Kriegsman Steven A |
CEO |
RSU Award |
208,334 |
$1.75 |
$364.58K |
208,334 |
| 2017-12-15 |
Caloz John Y |
Chief Financial Officer |
RSU Award |
58,334 |
$1.75 |
$102.08K |
58,334 |
| 2017-12-15 |
Ignarro Louis |
Director |
RSU Award |
30,000 |
$1.75 |
$52.5K |
30,000 |
| 2017-12-15 |
Brien Earl W |
Director |
RSU Award |
70,000 |
$1.75 |
$122.5K |
70,000 |
| 2017-12-15 |
Caldwell Joel K |
Director |
RSU Award |
30,000 |
$1.75 |
$52.5K |
30,000 |
| 2017-07-12 |
Caldwell Joel K |
Director |
Unknown |
- |
- |
- |
- |
| 2017-07-12 |
Caldwell Joel K |
Director |
RSU Award |
180,000 |
$0.67 |
$120.6K |
180,000 |
| 2017-06-13 |
Chawla Shanta M.d. |
Senior VP-drug Development |
Disposition |
120,000 |
$0.48 |
$57.6K |
- |
| 2016-12-15 |
Rubinfeld Joseph |
Director |
RSU Award |
180,000 |
$0.43 |
$77.4K |
180,000 |
| 2016-12-15 |
Kriegsman Steven A |
CEO |
RSU Award |
1,250,000 |
$0.43 |
$537.5K |
1,250,000 |
| 2016-12-15 |
Caloz John Y |
Chief Financial Officer |
RSU Award |
350,000 |
$0.43 |
$150.5K |
350,000 |
| 2016-12-15 |
Ignarro Louis |
Director |
RSU Award |
180,000 |
$0.43 |
$77.4K |
180,000 |
| 2016-12-15 |
Levitt Daniel J |
EVP and Chief Medical Officer |
RSU Award |
400,000 |
$0.43 |
$172K |
400,000 |
| 2016-12-15 |
Wieland Douglas Scott |
Sr VP - Drug Development |
RSU Award |
150,000 |
$0.43 |
$64.5K |
150,000 |
| 2016-12-15 |
Chawla Anita J |
Director |
RSU Award |
180,000 |
$0.43 |
$77.4K |
180,000 |
| 2016-12-15 |
Brien Earl W |
Director |
RSU Award |
180,000 |
$0.43 |
$77.4K |
180,000 |
| 2016-12-15 |
Kriegsman Steven A |
CEO |
RSU Award |
1,250,000 |
$0.43 |
$537.5K |
1,250,000 |
| 2016-12-02 |
Brien Earl W |
Director |
Disposition |
- |
- |
- |
60,000 |
| 2016-12-02 |
Brien Earl W |
Director |
RSU Award |
180,000 |
$0.52 |
$93.6K |
180,000 |
| 2016-12-02 |
Brien Earl W |
Director |
Disposition |
- |
- |
- |
61,484 |
| 2016-01-11 |
Ware Olivia C |
Officer |
Unknown |
- |
- |
- |
- |
| 2016-01-11 |
Ware Olivia C |
Chief Commercial Officer |
RSU Award |
350,000 |
$2.15 |
$752.5K |
350,000 |
| 2015-12-15 |
Wennekamp Richard L. |
Director |
RSU Award |
180,000 |
$2.15 |
$387K |
180,000 |
| 2015-12-15 |
Rubinfeld Joseph |
Director |
RSU Award |
180,000 |
$2.44 |
$439.2K |
180,000 |
| 2015-12-15 |
Kriegsman Steven A |
CEO and Chairman of Board |
RSU Award |
1,000,000 |
$2.44 |
$2.44M |
1,000,000 |
| 2015-12-15 |
Caloz John Y |
Chief Financial Officer |
RSU Award |
300,000 |
$2.44 |
$732K |
300,000 |
| 2015-12-15 |
Ignarro Louis |
Director |
RSU Award |
180,000 |
$2.44 |
$439.2K |
180,000 |
| 2015-12-15 |
Levitt Daniel J |
EVP and Chief Medical Officer |
RSU Award |
500,000 |
$2.44 |
$1.22M |
500,000 |
| 2015-12-15 |
Levin Ben |
SVP-legal Affairs/gc/secy |
RSU Award |
300,000 |
$2.44 |
$732K |
300,000 |
| 2015-12-15 |
Wieland Douglas Scott |
Sr VP - Drug Development |
RSU Award |
100,000 |
$2.44 |
$244K |
100,000 |
| 2015-12-15 |
Cohen Cheryl |
Director |
RSU Award |
180,000 |
$2.44 |
$439.2K |
180,000 |
| 2015-12-15 |
Chawla Anita J |
Director |
RSU Award |
180,000 |
$2.44 |
$439.2K |
180,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
